| Region: | |
| Category: |
(42 reports matching your criteria)
|
Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017
3/28/2013 | published by: MarketsandMarkets
... are used as therapeutics. In order to improve their clinical potential, second generation recombinants are being developed, each exhibiting improved efficiency and potency depending on their applications. The global protein engineering technologies market (2012-2017) report ...
|
read more...
|
$4,650.00
|
|
Ion Channel Modulators
3/1/2013 | published by: Global Industry Analysts
... of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Ion Channel Modulators profiles 48 companies including many key and niche ...
|
read more...
|
$4,500.00
|
|
Global and China Monoclonal Antibody Industry Report, 2013
1/1/2013 | published by: Research in China
... scale will reach USD78 billion in 2012. Meanwhile, monoclonal antibody is also a key major source of blockbuster drugs. In 2011, the sales of six monoclonal antibody agents as Infliximab (Johnson & Johnson), Etanercept (Amgen), ...
|
read more...
|
$2,500.00
|
|
Single-Use Technologies for Biopharmaceuticals: Global Markets
1/1/2013 | published by: BCC Research
... for 2012, and projections of compound annual growth rates (CAGRs) through 2017 In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, ...
|
read more...
|
$5,450.00
|
|
Global Immunoglobulin Products Market 2011-2015
12/14/2012 | published by: Infiniti Research Limited
... population. The Global Immunoglobulin Products market has also been witnessing the trend of an increase in mergers and acquisitions among the vendors. However, product recalls by the US Food and Drug Administration could pose a ...
|
read more...
|
$1,500.00
|
|
Global Monoclonal Antibodies Market 2011-2015
11/29/2012 | published by: Infiniti Research Limited
... cancer. The Global Monoclonal Antibodies market has also been witnessing the trend of the increasing use of monoclonal antibodies in the development of personalized medicines. However, the patent expiration of top-selling monoclonal antibody drugs could ...
|
read more...
|
$1,500.00
|
|
Global Kinase Inhibitors Market 2011-2015
11/9/2012 | published by: Infiniti Research Limited
... prevalence of disease. The Global Kinase Inhibitor market has also been witnessing the trend of an increase in the number of mergers and acquisitions. However, patent expiration of kinase inhibitors could pose a challenge to ...
|
read more...
|
$1,500.00
|
|
Global Biopharmaceutical Market Report & Forecast (2012-2017)
9/27/2012 | published by: IMARC
... stages of clinical development. These drugs have not only advanced the prevention and treatment of a number of life threatening diseases, but have also provided the thrust for the continued success of the pharmaceutical industry. ...
|
read more...
|
$1,200.00
|
|
Future Horizons in the Global Sexually-Transmitted Disease Market
8/31/2012 | published by: Venture Planning Group
... VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales forecasts by country and market segment, including: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs In addition ...
|
read more...
|
$8,500.00
|
|
Future Horizons in the Global Respiratory Disease Market
8/31/2012 | published by: Venture Planning Group
... Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales forecasts by country and market segment, including: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs In addition to test ...
|
read more...
|
$9,200.00
|
|
Future Horizons in the Global Hepatitis Diagnostic Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country
8/30/2012 | published by: Venture Planning Group
... report provides the 5- and 10-year test volume and sales forecasts by country for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in ...
|
read more...
|
$8,750.00
|
|
Global Immunodiagnostics Market 2011-2015
8/9/2012 | published by: Infiniti Research Limited
... has also been witnessing a shift from conventional to automated immunodiagnostic devices. However, the lack of reimbursements could pose a challenge to the growth of this market. TechNavio's report, the Global Immunodiagnostics Market 2011-2015, has ...
|
read more...
|
$1,500.00
|
|
Intravenous Immunoglobulin (IVIg)
8/1/2012 | published by: Global Industry Analysts
... for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 26 companies including many key and niche players such as Baxter International Inc., Beijing Tiantan Biological ...
|
read more...
|
$4,450.00
|
|
Global CA Tumor Markers Testing Market: Forecasts and Supplier Shares 2010-2015 (DataPack)
7/16/2012 | published by: Venture Planning Group
... by country and market segment. • The 2010-2015 sales forecasts by country and market segment. • The 2010 sales and market shares for major suppliers of CA Tumor Markerstests. Please note: The delivery time for ...
|
read more...
|
$3,900.00
|
|
Global PSA Testing Market: Forecasts and Supplier Shares 2010-2015 (DataPack)
7/16/2012 | published by: Venture Planning Group
... The 2010-2015 sales forecasts by country and market segment. • The 2010 sales and market shares for major suppliers of PSA tests. Please note: The delivery time for the electronic version of this report is ...
|
read more...
|
$2,900.00
|
|
Global AFP Testing Market: Forecasts and Supplier Shares 2010-2015 (DataPack)
7/16/2012 | published by: Venture Planning Group
... shares for major suppliers of AFP tests. Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.
|
read more...
|
$2,900.00
|
|
Global CEA Testing Market: Forecasts and Supplier Shares 2010-2015 (DataPack)
7/16/2012 | published by: Venture Planning Group
... The 2010-2015 sales forecasts by country and market segment. • The 2010 sales and market shares for major suppliers of Please note: The delivery time for the electronic version of this report is between 1-3 ...
|
read more...
|
$2,900.00
|
|
Kinase Inhibitors: Global Markets
6/1/2012 | published by: BCC Research
... U.S. market for kinase inhibitors reached $10.8 billion in 2010 and came down to $10.4 billion in 2011. The market is expected to reach $11.6 billion by 2016, a CAGR of 2.2%. The European market ...
|
read more...
|
$5,450.00
|
|
Global Protein Therapeutics Market Forecast to 2015
4/1/2012 | published by: RNCOS
... from cancer to metabolic disorders. Despite the post-recessionary impact worldwide causing major slump in the healthcare spending, the protein therapeutics market continued to grow at its retained speed. According to our report, the market still ...
|
read more...
|
$1,800.00
|
|
Immunochemicals
4/1/2012 | published by: Global Industry Analysts
... Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 129 companies including many key and niche ...
|
read more...
|
$4,500.00
|
|
Laboratory Chemical Reagents
3/1/2012 | published by: Global Industry Analysts
... Reagents, Enzymes, & Others), Biochemistry (IVD), Cytokine & Chemokine Testing, Cell/Tissue Culture, Carbohydrate Analysis, Immunohistochemistry, and Environmental Testing (Pesticide Residues, & Others). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, ...
|
read more...
|
$4,950.00
|
|
Antibody Drugs: Technologies and Global Markets
2/1/2012 | published by: BCC Research
... forecast period, the global mAb market is expected to rise at a compound annual growth rate (CAGR) of 5.3% to nearly $58 billion in 2016. The U.S. is projected to be the largest single market ...
|
read more...
|
$5,450.00
|
|
The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies), 4th Edition
1/1/2012 | published by: Kalorama Information
... oncology therapeutics. The report focuses on several segments for cancer treatment including: Chemotherapy, - Subcategories include Alkylating Agents, Antimetabolites, Cytotoxic Agents, Plant Derivatives - Brands such as Elotaxin, Taxotere, Gemzar, Alimta and Temodar, with Market ...
|
read more...
|
$1,995.00
|
|
The Global Competitive Landscape of Antibody Drug Development in Cancer: The Faster Route to Consider Your Options and Position of Others
9/27/2011 | published by: BioSeeker Group AB
... are number one, two or further down the ladder in this highly competitive market. Locate the right drugs to benchmark against and see were others may have succeeded or failed before you. This report comprises ...
|
read more...
|
$3,675.00
|
|
Therapeutic Monoclonal Antibodies: World Market 2011-2021
9/19/2011 | published by: Visiongain
... markets have the greatest potential for growth? You can find predictions and explanations in this study. It covers cancer, autoimmune diseases and other applications for therapeutic mAbs. Discover mAb treatment revenues at total world, submarket, ...
|
read more...
|
$2,739.00
|
